Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Special Education
      • Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • DSM-5’s First Pages and ICD-10’s Billing Codes
  • Medical & Educational Downloads
  • Contact Us
Select Page

Machine Learning Model for Response to Internet-Delivered CBT vs Antidepressant Medication

by jlohrconsulting | Nov 6, 2025 | Uncategorized

JAMA Netw Open. 2025 Nov 3;8(11):e2541639. doi: 10.1001/jamanetworkopen.2025.41639. ABSTRACT IMPORTANCE: Many treatments exist for depression, yet none are universally effective. Multivariable predictive models support personalized treatment selection. OBJECTIVE: To...

Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric Patients

by jlohrconsulting | Nov 6, 2025 | Uncategorized

JAMA Ophthalmol. 2025 Nov 6. doi: 10.1001/jamaophthalmol.2025.4243. Online ahead of print. ABSTRACT IMPORTANCE: Apraclonidine, a topical α-2 adrenergic agonist, reverses anisocoria in patients with Horner syndrome, a disruption of the sympathetic chain to 1 eye and...

Machine Learning Model for Response to Internet-Delivered CBT vs Antidepressant Medication

by jlohrconsulting | Nov 6, 2025 | Uncategorized

JAMA Netw Open. 2025 Nov 3;8(11):e2541639. doi: 10.1001/jamanetworkopen.2025.41639. ABSTRACT IMPORTANCE: Many treatments exist for depression, yet none are universally effective. Multivariable predictive models support personalized treatment selection. OBJECTIVE: To...

Trends in Concurrent Psychiatric Comorbidities in Alcohol-Associated Liver Disease: A Nationwide Study from 2015-2023

by jlohrconsulting | Nov 6, 2025 | Uncategorized

Dig Dis Sci. 2025 Nov 6. doi: 10.1007/s10620-025-09494-x. Online ahead of print. ABSTRACT BACKGROUND: Psychiatric comorbidities with alcohol use disorder increase the risk of alcohol abuse and relapse. However, updated epidemiologic trends of comorbid psychiatric...

Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric Patients

by jlohrconsulting | Nov 6, 2025 | Uncategorized

JAMA Ophthalmol. 2025 Nov 6. doi: 10.1001/jamaophthalmol.2025.4243. Online ahead of print. ABSTRACT IMPORTANCE: Apraclonidine, a topical α-2 adrenergic agonist, reverses anisocoria in patients with Horner syndrome, a disruption of the sympathetic chain to 1 eye and...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments